EU drugs regulator studying expanded use of COVID-19 drug remdesivir

Reuters | Updated: 23-02-2021 15:12 IST | Created: 23-02-2021 14:44 IST
EU drugs regulator studying expanded use of COVID-19 drug remdesivir
Remdesivir is an investigational anti-viral therapy developed by Gilead Image Credit: ANI

Europe's drugs regulator said on Tuesday it is evaluating the use of remdesivir in COVID-19 patients who do not need oxygen support after developer Gilead Sciences submitted an application to extend the medicine's use.

Europe had conditionally approved remdesivir, sold under the brand name Veklury, in July for treating COVID-19 in adults and adolescents with pneumonia requiring oxygen support.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Why unequal access to coronavirus vaccines is a threat to us all

... ...

India’s love affair with fossil fuels: the path to sustainable development?

... ...

Videos

Latest News

Hearing for Hong Kong democracy activists resumes after marathon session

The proceedings for 47 Hong Kong democracy activists charged with conspiracy to commit subversion resume on Tuesday, following a marathon hearing that extended well past midnight before it was adjourned after one of the defendants fainted.L...

Boeing, Australian air force say pilotless, fighter-like jet completed first test flight

Boeing Co and the Royal Australian Air Force RAAF said on Tuesday they had completed the first flight test on a pilotless fighter-like jet designed to operate in conjunction with crewed aircraft. The Loyal Wingman, the first military aircra...

Saudi envoy disputes crown prince role in Khashoggi killing

Saudi Arabias UN ambassador on Monday disputed the US intelligence report which concluded that the Saudi crown prince approved an operation to kill or capture dissident journalist Jamal Khashoggi, saying in a tweet Let us all move forward t...

'Free rein to rule': El Salvador's Bukele set for crushing mid-term win

El Salvadoran President Nayib Bukele was on course to win a super-majority in Congress in mid-term elections, a preliminary vote count showed on Monday, with his party and allies likely reducing once dominant rivals to a handful of legislat...

Give Feedback